Monday, March 02, 2026

8 days
RFK appoints two new members to CDC vaccine advisory panel ahead of meeting (8)
9 days
Family denied respite care as desperate parents plead for help (5)
9 days
Rezatapopt shows proof-of-concept reactivating mutant p53 in patients (8)
9 days
Novartis closes Avidity deal; Atrium Therapeutics spinout launches (2)


In Detail Full day, Monday, March 02, 2026, Timezone: America/Chicago

RFK Jr. names 2 new members to CDC vaccine panel / Beckers

Erica Cerutti / beckershospitalreview - HHS Secretary Robert F. Kennedy Jr. appointed two new members to the CDC’s vaccine advisory committee Feb. 27, ahead of a rescheduled meeting in mid-March where members are expected to review COVID-19 vaccine recommendations. Mr. Kennedy said Sean Downing…

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety #infectiousdisease

HHS strikes deal with 53 medical schools to expand nutrition training

5 days / beckershospitalreview / Erica Cerutti

Dozens of medical schools meet RFK Jr.'s call for greater nutrition education

5 days / fiercehealthcare

Minnesota sues feds over nearly $244M in frozen Medicaid funds

6 days / beckershospitalreview / Elizabeth Casolo

In South Carolina Measles Outbreak, Vaccine Skepticism Led to Largest Outbreak Since 2000

8 days / nytimes / Anemona Hartocollis and Kaoly Gutierrez

U.S. tops 1,100 measles cases this year as outbreaks grow

8 days / medicalxpress

Two more members added to ACIP ahead of March meeting

8 days / endpoints / Max Bayer

Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting

8 days / fiercehealthcare

RFK Jr. names 2 new members to CDC vaccine panel

9 days / beckershospitalreview / Erica Cerutti

Monday, March 2, 2026, 3:24 pm / permalink 20024 / 8 stories in 8 days


Parents of gravely ill child refused respite care / BBC

bbc - Birmingham Children's Trust refused respite help and suggested training grandparents to help.

#healthcare #publichealth #governmentpolicy #behavioralhealth

'Moment of reckoning' needed in social care, says Louise Casey

5 days / bbc

Trying to get social care can be 'horrendous', Baroness Casey tells BBC

6 days / bbc

Families Defend Disability Services Amid Medicaid Cuts

9 days / kffhealthnews / Bram Sable-Smith

E-biking boosts health, physical activity levels, study finds

12 days / medicalxpress

Parents of gravely ill child refused respite care

12 days / bbc

Monday, March 2, 2026, 2:22 am / permalink 19974 / 5 stories in 9 days


Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours / ESMO

esmo - Findings from the PYNNACLE study

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology

Rezatapopt Shows Early Activity in TP53 Y220C–Mutated Solid Tumors

7 days / oncodaily

Targeting the untargetable cancer—rezatapopt, an oral p53 reactivator

9 days / medicalxpress

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation in Patients with TP53 Y220C-mutated Solid Tumours

9 days / esmo

Jayastu Senapati: Trial of Rezatapopt in TP53-Y220C Mutated MDS/AML

10 days / oncodaily

Rashid Lui: First-in-Class Oral Selective p53 Reactivator Looks Promising

11 days / oncodaily

Xin Lu on Targeting Mutant p53 in Solid Tumors with Rezatapopt – NEJM Group

11 days / oncodaily

Florent Peyraud: Restoring Function to a Variant of p53 in Solid Tumors

12 days / oncodaily

Aydah AlAwadhi: Targeting the “Undruggable” p53 – A Long Awaited Proof of Principle

12 days / oncodaily

Monday, March 2, 2026, 2:22 am / permalink 19973 / 8 stories in 9 days


Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

Lei Lei Wu / endpoints - Atrium Therapeutics launched Friday morning as Novartis closed the $12 billion deal to buy Avidity Biosciences and its RNA muscle therapies. The spinout will take on Avidity’s early-stage programs for genetic cardiomyopathies — heart muscle diseases ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance

Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions

10 days / medcitynews / Frank Vinluan

Novartis closes Avidity deal as rare heart disease spinout launches

12 days / endpoints / Lei Lei Wu

Monday, March 2, 2026, 12:23 am / permalink 19968 / 2 stories in 9 days


StackHealth Time Machine



Outgoing Stories

Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.3 hours

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.3 hours

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.4 hours

White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.4 hours

MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.4 hours

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.4 hours

Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.4 hours

Springing forward worsens sleep and sparks health complaints 8 stories in 87.4 hours

Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.4 hours

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.4 hours


More StackHealth

Bluesky:


NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.